| Literature DB >> 16106210 |
Elyse Murphy1, Sarah Martin, Jardiolyn Valino Patterson.
Abstract
As the use of intravenous immunoglobulin (IGIV) continues to expand, infusion nurses have a greater need for a comprehensive understanding of the product, patient risk factors, and comorbidities when developing guidelines for administering IGIV. Because immunoglobulin therapy is a blood derivative product, many nurses may not have as much experience administering this type of infusion. This article provides an in-depth overview of immunoglobulin therapy and helps to define the infusion nurse's major role in coordinating, assessing, and ensuring patient safety during IGIV administration.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16106210 DOI: 10.1097/00129804-200507000-00009
Source DB: PubMed Journal: J Infus Nurs ISSN: 1533-1458